Chemical Structure : GCJ-490A
货号: PC-25846Not For Human Use, Lab Use Only.
GCJ-490A is a pan-histone deacetylase (HDAC) inhibitor that exerts potent inhibitory activity against HDAC1, HDAC3, and HDAC6 with IC50 of 3.64, 3.02 and 4.96 nM respectively.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
GCJ-490A is a pan-histone deacetylase (HDAC) inhibitor that exerts potent inhibitory activity against HDAC1, HDAC3, and HDAC6 with IC50 of 3.64, 3.02 and 4.96 nM respectively.
GCJ-490A also inhibits HDAC2 (IC50=13.26 nM), HDAC8 (IC50=16.84 nM), HDAC10 (IC50=1.98 nM)and HDAC11 (IC50=77.82 nM), dos not inhibit HDAC4/5/7/9 and SIRT1/2/3.
GCJ-490A shows potent antiproliferative activity against NCI-N87 and T47D cells with IC50 values of 28 and 40 nM, respectively.
GCJ-490A (50 mg/kg) showsgood efficacy in solid tumors such as the HT-29 model, also directly decrease the incidence of colitis-associated cancer.
GCJ-490A effectively inhibits NSCLC cell proliferation, including gefitinib resistant A549, H460, HCC827/GR6, and H1975 (IC50=20-180 nM), induces apoptosis in vitro and in vivo.
GCJ-490A suppresses c-Met expression through IKKα and overcomes gefitinib resistance in NSCLC.
| 分子量 | 490.60 | |
| 分子式 | C25H22N4O3S2 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
1. He T, et al. Cancer Biol Med. 2022 Feb 22;19(8):1172-92.
2. Zhang WX, et al. Acta Pharmacol Sin. 2025 Oct 1. doi: 10.1038/s41401-025-01646-z.
3. hang SW, et al. J Med Chem. 2020;63:804–15.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright